Table 1. Patient Characteristics of primary study cohort.

Patient Characteristics	Class	Value
Gender	Total (male/female)	62 (26/36)
Age at Diagnosis (yrs)	Average (range)	52 (26.7–76.5)
CR After 1st or 2nd Induction	Achieved (total/percentage)	51 (56/91%)
Overall survival	median in days (range)	828 (36–3180)
Mutations
DNMT3A mutation	n (percentage)	28 (48%)
IDH1/2 mutation	n (percentage)	13 (22%)
IDH1 mutation	n (percentage)	3 (5.0%)
IDH2 mutation	n (percentage)	11 (18%)
NPM1 mutation	n (percentage)	30 (49%)
FLT3 any	n (percentage)	23 (37%)
FLT3-ITD	n (percentage)	22 (36%)
FLT3 TKD-KTD	n (percentage)	2 (3.3%)